NEWYou can now listen to Fox News articles! U.S. lawmakers are growing concerned with ongoing …
Read More »Higher-dose obesity medication wins FDA approval, promises greater weight loss
Novo Nordisk to slash Wegovy, Ozempic list prices Board certified rheumatologist Dr. Mahsa Tehrani discusses Novo Nordisk’s decision to dramatically cut the U.S. list prices for its popular diabetes and weight-loss drugs Ozempic and Wegovy on ‘America Reports.’ NEWYou can now listen to Fox News articles! The U.S. Food and …
Read More »
Latest Breaking News Online News Portal




































